Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in painful diabetic peripheral neuropathy
NCT00143156Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in diabetic peripheral neuropathy (DPN) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Weekly Mean Pain Score at 12 weeks. Started Mar 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00143156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143156.